These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8684559)

  • 1. Correlation between serotonin concentration and blood pressure in kidney transplant recipients treated with cyclosporine.
    Azzadin A; Malyszko J; Malyszko JS; Buczko W; Mysliwiec M
    Nephron; 1996; 72(2):336-7. PubMed ID: 8684559
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased vascular resistance and not salt retention characterizes cyclosporine A-induced hypertension: report in an anuric patient.
    Wahba IM; Bennett WM
    Am J Transplant; 2007 Aug; 7(8):2042-6. PubMed ID: 17578503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial hypertension in renal transplantation.
    Sandrini S; Gaggia P; Bracchi M; Gaggiotti M; Brunori G; Maiorca R
    Contrib Nephrol; 1996; 119():16-25. PubMed ID: 8783585
    [No Abstract]   [Full Text] [Related]  

  • 7. Intensive observation of toxic side effects after several-year of cyclosporin treatment in kidney transplant patient.
    Asćerić M; Avdić S; Nukić S; Vrabac-Mujcinagić M
    Bosn J Basic Med Sci; 2007 May; 7(2):132-5. PubMed ID: 17489748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
    Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
    J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cyclosporine A and FK506 on 24 h blood pressure monitoring in kidney transplant recipients.
    Hohage H; Brückner D; Arlt M; Buchholz B; Zidek W; Spieker C
    Clin Nephrol; 1996 May; 45(5):342-4. PubMed ID: 8738668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation.
    Rigatto O; Rush D; Perry Y; Walker S; Bose R; Bolli P
    Transplant Proc; 1997 Sep; 29(6):2591-2. PubMed ID: 9290755
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine versus tacrolimus maintenance therapy in renal transplant.
    Alghamdi S; Nabi Z; Skolnik E; Alkorbi L; Albaqumi M
    Exp Clin Transplant; 2011 Jun; 9(3):170-4. PubMed ID: 21649564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity associated with cyclosporine and FK506.
    Klintmalm GB; Gonwa TA
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):11-9. PubMed ID: 9346596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal alopecia areata during systemic cyclosporine A therapy.
    Cerottini JP; Panizzon RG; de Viragh PA
    Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of C0 and C2 levels with cyclosporine side effects in kidney transplantation.
    Rodrigo E; Ruiz JC; Angeles de Cos M; Ruiz J; Gago M; Piñera C; Sánchez B; González-Cotorruelo J; Gómez-Alamillo C; Arias M
    Transplant Proc; 2009; 41(6):2328-31. PubMed ID: 19715910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
    Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
    Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
    J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients.
    Thakur V; Kumar R; Dhawan IK
    Ann Clin Biochem; 2002 Jan; 39(Pt 1):70-2. PubMed ID: 11853195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.